home / stock / veru / veru articles

VERU Articles, Veru Inc.

Stock Information
Company Name: Veru Inc.
Stock Symbol: VERU
Market: NASDAQ
Website: verupharma.com
Menu
VERU VERU Quote VERU Short VERU News VERU Articles VERU Message Board
Get VERU Alerts

News, Short Squeeze, Breakout and More Instantly...
Veru to Participate in the Leerink Therapeutics Forum: I&I and Metabolism | Benzinga

MIAMI, FL, July 02, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing inno...
Veru to Present at the American Diabetes Association's 84th Scientific Sessions | Benzinga

MIAMI, FL, June 10, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing inno...

Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of Bank of Montreal (NYSE:BMO) fell sharply during Wednesday's session after the company reported worse-than-expected second-quarter fi...

Comstock And 2 Other Stocks Under $2 Insiders Are Buying | Benzinga

The Dow Jones index closed lower by over 200 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern aro...
Veru to Present at the Jefferies Global Healthcare Conference | Benzinga

MIAMI, FL, May 22, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innov...

Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week | Benzinga

MIAMI, FL, May 14, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innov...

Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program | Benzinga

--Phase 2b clinical study of enobosarm in combination with semaglutide (Wegovy®*) for high quality weight loss is actively enrolling-- -...
Veru to Present at the GLP-1 Based Therapeutics Summit | Benzinga

MIAMI, FL, May 02, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innov...

Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024 | Benzinga

MIAMI, FL, May 01, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innov...

Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11 | Benzinga

MIAMI, FL, April 25, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing inn...
Next 10